A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abbott Laboratories stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,490,064 shares of ABT stock, worth $173 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,490,064
Previous 1,654,664 9.95%
Holding current value
$173 Million
Previous $172 Million 1.19%
% of portfolio
0.31%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $16.5 Million - $19.4 Million
-164,600 Reduced 9.95%
1,490,064 $170 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $7.62 Million - $8.5 Million
75,600 Added 4.79%
1,654,664 $172 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $15.2 Million - $16.8 Million
-138,761 Reduced 8.08%
1,579,064 $179 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $28.4 Million - $34.7 Million
314,561 Added 22.42%
1,717,825 $189 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $7.91 Million - $9.5 Million
82,846 Added 6.27%
1,403,264 $136 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $14 Million - $15.6 Million
-139,266 Reduced 9.54%
1,320,418 $144 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $11 Million - $13 Million
-113,780 Reduced 7.23%
1,459,684 $148 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $5.77 Million - $6.77 Million
-60,700 Reduced 3.71%
1,573,464 $173 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $18.3 Million - $21.2 Million
-189,400 Reduced 10.39%
1,634,164 $158 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $2.34 Million - $2.83 Million
-22,900 Reduced 1.24%
1,823,564 $198 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $4.31 Million - $5.26 Million
-37,800 Reduced 2.01%
1,846,464 $219 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $25.9 Million - $31.7 Million
-223,800 Reduced 10.62%
1,884,264 $265 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $20.7 Million - $22.9 Million
177,200 Added 9.18%
2,108,064 $249 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $3.13 Million - $3.69 Million
-29,600 Reduced 1.51%
1,930,864 $224 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $1.44 Million - $1.69 Million
-13,203 Reduced 0.67%
1,960,464 $235 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $897,750 - $978,291
-8,550 Reduced 0.43%
1,973,667 $216 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $3.32 Million - $4.04 Million
36,265 Added 1.86%
1,982,217 $216 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $6.11 Million - $7.82 Million
-79,826 Reduced 3.94%
1,945,952 $178 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $2.51 Million - $3.67 Million
40,005 Added 2.01%
2,025,778 $160 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $12.6 Million - $14 Million
-160,659 Reduced 7.48%
1,985,773 $172 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $461,904 - $500,848
5,644 Added 0.26%
2,146,432 $180 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $11.2 Million - $13.1 Million
154,245 Added 7.76%
2,140,788 $180 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $40 Million - $48.4 Million
-604,679 Reduced 23.34%
1,986,543 $159 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $11.1 Million - $12.6 Million
-169,225 Reduced 6.13%
2,591,222 $187 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $35 Million - $42.3 Million
-576,200 Reduced 17.27%
2,760,447 $203 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $43.6 Million - $48.1 Million
-757,736 Reduced 18.51%
3,336,647 $204 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $9.37 Million - $10.6 Million
-166,455 Reduced 3.91%
4,094,383 $245 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $2.98 Million - $3.2 Million
55,600 Added 1.32%
4,260,838 $243 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $202 Million - $226 Million
4,205,238
4,205,238 $224 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.